| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A general measles vaccination campaign in urban Guinea-Bissau: Comparing child mortality among participants and non-participants
|
Byberg, S.
|
|
2017
|
35 |
1 |
p. 33-39
7 p.
|
artikel
|
| 2 |
Age-specific effectiveness following each dose of acellular pertussis vaccine among infants and children in New Zealand
|
Radke, Sarah
|
|
2017
|
35 |
1 |
p. 177-183
7 p.
|
artikel
|
| 3 |
An interferon inducing porcine reproductive and respiratory syndrome virus vaccine candidate elicits protection against challenge with the heterologous virulent type 2 strain VR-2385 in pigs
|
Fontanella, Eve
|
|
2017
|
35 |
1 |
p. 125-131
7 p.
|
artikel
|
| 4 |
Antigenic variation of LaSota and genotype VII Newcastle disease virus (NDV) and their efficacy against challenge with velogenic NDV
|
Yang, Hui-ming
|
|
2017
|
35 |
1 |
p. 27-32
6 p.
|
artikel
|
| 5 |
A partially purified outer membrane protein VirB9-1 for low-cost nanovaccines against Anaplasma marginale
|
Zhao, Liang
|
|
2017
|
35 |
1 |
p. 77-83
7 p.
|
artikel
|
| 6 |
Challenges to estimating vaccine impact using hospitalization data
|
Schuck-Paim, Cynthia
|
|
2017
|
35 |
1 |
p. 118-124
7 p.
|
artikel
|
| 7 |
Changing molecular epidemiology of rotavirus infection after introduction of monovalent rotavirus vaccination in Scotland
|
Mukhopadhya, Indrani
|
|
2017
|
35 |
1 |
p. 156-163
8 p.
|
artikel
|
| 8 |
Characterization of guinea pig T cell responses elicited after EP-assisted delivery of DNA vaccines to the skin
|
Schultheis, Katherine
|
|
2017
|
35 |
1 |
p. 61-70
10 p.
|
artikel
|
| 9 |
Chlamydia suis and Chlamydia trachomatis induce multifunctional CD4 T cells in pigs
|
Käser, T.
|
|
2017
|
35 |
1 |
p. 91-100
10 p.
|
artikel
|
| 10 |
Clinician knowledge, clinician barriers, and perceived parental barriers regarding human papillomavirus vaccination: Association with initiation and completion rates
|
Rutten, Lila J. Finney
|
|
2017
|
35 |
1 |
p. 164-169
6 p.
|
artikel
|
| 11 |
Comparative analysis of influenza A(H3N2) virus hemagglutinin specific IgG subclass and IgA responses in children and adults after influenza vaccination
|
Manenti, Alessandro
|
|
2017
|
35 |
1 |
p. 191-198
8 p.
|
artikel
|
| 12 |
Comparison of homologous and heterologous prime-boost immunizations combining MVA-vectored and plant-derived VP2 as a strategy against IBDV
|
Richetta, Matías
|
|
2017
|
35 |
1 |
p. 142-148
7 p.
|
artikel
|
| 13 |
Country specific predictions of the cost-effectiveness of malaria vaccine RTS,S/AS01 in endemic Africa
|
Galactionova, Katya
|
|
2017
|
35 |
1 |
p. 53-60
8 p.
|
artikel
|
| 14 |
Development of novel replication-defective lymphocytic choriomeningitis virus vectors expressing SIV antigens
|
Penaloza MacMaster, Pablo
|
|
2017
|
35 |
1 |
p. 1-9
9 p.
|
artikel
|
| 15 |
Editorial Board/Aims and Scope
|
|
|
2017
|
35 |
1 |
p. IFC-
1 p.
|
artikel
|
| 16 |
Hepatitis B vaccine alone may be enough for preventing hepatitis B virus transmission in neonates of HBsAg (+)/HBeAg (−) mothers
|
Lu, Ying
|
|
2017
|
35 |
1 |
p. 40-45
6 p.
|
artikel
|
| 17 |
H1:IC31 vaccination is safe and induces long-lived TNF-α+IL-2+CD4 T cell responses in M. tuberculosis infected and uninfected adolescents: A randomized trial
|
Mearns, Helen
|
|
2017
|
35 |
1 |
p. 132-141
10 p.
|
artikel
|
| 18 |
Humoral and cellular response after varicella vaccination in VZV IgG seronegative kidney transplant candidates
|
Kho, Marcia M.L.
|
|
2017
|
35 |
1 |
p. 71-76
6 p.
|
artikel
|
| 19 |
Impact of the national targeted Hepatitis A immunisation program in Australia: 2000–2014
|
Thompson, Craig
|
|
2017
|
35 |
1 |
p. 170-176
7 p.
|
artikel
|
| 20 |
Improving adolescent HPV vaccination in a randomized controlled cluster trial using the 4 Pillars™ practice Transformation Program
|
Zimmerman, Richard K.
|
|
2017
|
35 |
1 |
p. 109-117
9 p.
|
artikel
|
| 21 |
Influenza vaccination in people with type 2 diabetes, coverage, predictors of uptake, and perceptions. Result of the MADIABETES cohort a 7years follow up study
|
Jiménez-Garcia, Rodrigo
|
|
2017
|
35 |
1 |
p. 101-108
8 p.
|
artikel
|
| 22 |
Map of different vaccine supply chain efficiency measures
|
Haidari, Leila A.
|
|
2017
|
35 |
1 |
p. 199-200
2 p.
|
artikel
|
| 23 |
Rotavirus vaccine effectiveness in low-income settings: An evaluation of the test-negative design
|
Schwartz, Lauren M.
|
|
2017
|
35 |
1 |
p. 184-190
7 p.
|
artikel
|
| 24 |
Structure-based design of broadly protective group a streptococcal M protein-based vaccines
|
Dale, James B.
|
|
2017
|
35 |
1 |
p. 19-26
8 p.
|
artikel
|
| 25 |
Systemic immunization with rPotD reduces Streptococcus pneumoniae nasopharyngeal colonization in mice
|
Converso, T.R.
|
|
2017
|
35 |
1 |
p. 149-155
7 p.
|
artikel
|
| 26 |
The recombinant N-terminal domain of spike proteins is a potential vaccine against Middle East respiratory syndrome coronavirus (MERS-CoV) infection
|
Jiaming, Lan
|
|
2017
|
35 |
1 |
p. 10-18
9 p.
|
artikel
|
| 27 |
Vaccination against hepatitis B virus among people who inject drugs – A 20year experience from a Swedish needle exchange program
|
Alanko Blomé, M.
|
|
2017
|
35 |
1 |
p. 84-90
7 p.
|
artikel
|
| 28 |
ViroSpot microneutralization assay for antigenic characterization of human influenza viruses
|
van Baalen, Carel A.
|
|
2017
|
35 |
1 |
p. 46-52
7 p.
|
artikel
|
Tijdschrift beschrijving